===
EQS-News: Drägerwerk AG & Co. KGaA / Key word(s): Personnel/Sustainability
Drägerwerk AG & Co. KGaA: Dräger makes sustainability and quality an Executive Board responsibility
2024-05-08 / 16:45 CET/CEST
The issuer is solely responsible for the content of this announcement.
Dräger makes sustainability and quality an Executive Board responsibility
Stefanie Hirsch will be appointed to the Executive Board as of July 1, 2024
Dräger is creating a new, additional Executive Board position for sustainability and quality. At its meeting today, the
Supervisory Board of Drägerwerk Verwaltungs AG decided to appoint Stefanie Hirsch to the Executive Board as Chief
Sustainability and Quality Officer as of July 1, 2024.
"Sustainability has always been deeply rooted in Dräger's corporate culture and is becoming increasingly important for
the future. It is a cross-cutting topic and affects all processes and areas of our company. The same applies to
quality, one of our four strengths and a cornerstone of our company. I am delighted to have Stefanie Hirsch as an
experienced and committed colleague on the Executive Board." - Stefan Dräger, CEO of Drägerwerk Verwaltungs AG.
Stefanie Hirsch was born in Worms, Germany in 1975 and studied biotechnology at Mannheim University of Applied
Sciences. She began her professional career at Abbott Diagnostics in the Research & Development department. This was
followed by various management positions in the areas of Operations, Quality and Regulatory Affairs, including abroad.
She has also worked at Ortho-Clinical Diagnostics, a global provider of products and services for transfusion services
and clinical laboratories, where she led the quality management and regulatory affairs teams in the company's
international sales & service offices in the EMEA and Asia regions.
Hirsch has been with Dräger since 2018 and is Head of Quality and Regulatory Affairs in Medical Technology. She has
also been Head of Corporate Quality & Regulatory Affairs, including Global Environmental Health and Safety Management,
since 2020.
Image material:
Photo: Stefanie Hirsch will be appointed to the Executive Board of Drägerwerk Verwaltungs AG as of July 1, 2024. ©
Drägerwerk AG & Co. KGaA
Dräger. Technology for Life®
Dräger is an international leader in the fields of medical and safety technology. Our products protect, support, and
save lives. Founded in 1889, Dräger generated revenues of around EUR 3,4 billion in 2023. The Dräger Group is currently
present in over 190 countries and has more than 16,000 employees worldwide. For more information, visit www.draeger.com
.

2024-05-08 CET/CEST Dissemination of a Corporate News, transmitted by EQS News - a service of EQS Group AG.
The issuer is solely responsible for the content of this announcement.
The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases.

Archive at www.eqs-news.com  
Language:     English 
Company:      Drägerwerk AG & Co. KGaA 

Moislinger Allee 53-55
23558 Lübeck
Germany

Phone:        +49 (0)451 882-0 
Fax:          +49 (0)451 882-2080 
E-mail:       info@draeger.com 
Internet:     www.draeger.com 
ISIN:         DE0005550602, DE 000 555 063 6, DE 000 555 071 9 
WKN:          555060, 555063 Vorzüge, 555071 Genussschein D 
Indices:      SDAX 
Listed:       Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Stuttgart, 

Tradegate Exchange
EQS News ID: 1899015

End of News EQS News Service
===
1899015 2024-05-08 CET/CEST

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=download2_file&code_str=aaea7a5e448e7efd32de8b92d16508bb

Image link: https://eqs-cockpit.com/cgi-bin/fncls.ssp?fn=show_t_gif&application_id=1899015&application_name=news

END) Dow Jones Newswires

May 08, 2024 10:45 ET (14:45 GMT)